| Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults (NCT06669234) | Regeneron Pharmaceuticals | 2025-03-06 |
| Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants (NCT05490030) | Novartis Pharmaceuticals | 2025-03-06 |
| A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes (NCT06924320) | Pfizer | 2025-03-06 |
| Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis (NCT06592703) | Rennes University Hospital | 2025-03-06 |
| Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors (NCT06823609) | Qilu Pharmaceutical Co., Ltd. | 2025-03-06 |
| Increasing Affordable Fruits and Vegetables for Families With Food Insecurity (NCT06828445) | University of South Carolina | 2025-03-06 |
| A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors (NCT06716138) | Avistone Biotechnology Co., Ltd. | 2025-03-06 |
| A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004 (NCT06857695) | AstraZeneca | 2025-03-06 |
| Study of CMTS1215 Injection in Patients With Solid Tumors (NCT07556276) | The Second Hospital of Nanjing Medical University | 2025-03-06 |
| Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors (NCT06563375) | M.D. Anderson Cancer Center | 2025-03-05 |
| Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions (NCT06855576) | HALEON | 2025-03-05 |
| A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease (NCT06822517) | Ventus Therapeutics U.S., Inc. | 2025-03-05 |
| Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 (NCT06714253) | RiboX Therapeutics Ltd. | 2025-03-05 |
| A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) (NCT06548230) | M.D. Anderson Cancer Center | 2025-03-05 |
| A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations (NCT06835569) | Alterome Therapeutics, Inc. | 2025-03-05 |
| Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso (NCT06652737) | Sanaria Inc. | 2025-03-04 |
| A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2) (NCT06796907) | GlaxoSmithKline | 2025-03-04 |
| Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults (NCT06665828) | Regeneron Pharmaceuticals | 2025-03-04 |
| Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells (NCT04254419) | Nationwide Children's Hospital | 2025-03-04 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NCT06955988) | Allist Pharmaceuticals, Inc. | 2025-03-04 |
| Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma (NCT07453446) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2025-03-04 |
| EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors (NCT06541639) | Peking University | 2025-03-04 |
| A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis (NCT06688435) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2025-03-04 |
| A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM (NCT06845202) | Alnylam Pharmaceuticals | 2025-03-03 |
| Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients (NCT06777719) | Nantes University Hospital | 2025-03-03 |
| Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients (NCT07169500) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady State (NCT07146711) | Berlin-Chemie AG Menarini Group | 2025-03-03 |
| VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease (NCT06874621) | Voyager Therapeutics | 2025-03-03 |
| Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT06560762) | Secretome Therapeutics | 2025-03-03 |
| A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer (NCT06863233) | Memorial Sloan Kettering Cancer Center | 2025-03-03 |
| Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia (NCT06613217) | Pacylex Pharmaceuticals | 2025-03-03 |
| A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old (NCT06944717) | Vaxart | 2025-03-03 |
| A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects (NCT06837155) | Taisho Pharmaceutical Co., Ltd. | 2025-03-03 |
| Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM (NCT07109323) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| Dexamethasone Versus Dexmedetomidine in IPACK Block to Reduce Pain Post Arthroscopic Knee Surgeries (NCT07024043) | Ain Shams University | 2025-03-03 |
| A Study of Subcutaneous DR-01 in Healthy Volunteers (NCT06766864) | Dren Bio | 2025-03-03 |
| A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects. (NCT06839131) | Shanghai Pharmaceuticals Holding Co., Ltd | 2025-03-02 |
| Comparison of the Efficacy of Chemical Genicular Nerve Neurolysis Using Alcohol or Phenol Versus Radiofrequency Ablation Under Ultrasound Guidance for Pain Management in Patients With Knee Osteoarthritis (NCT06798038) | Tanta University | 2025-03-01 |
| A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis (NCT06900192) | Stanford University | 2025-03-01 |
| PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor (NCT06014385) | Yale University | 2025-03-01 |
| Trial of Gum Chewing to Enhance the Restoration of Intestinal Motility in Colorectal Cancer Surgery (NCT06860685) | Sichuan Cancer Hospital and Research Institute | 2025-03-01 |
| Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants (NCT06690515) | PT Bio Farma | 2025-03-01 |
| Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia (NCT06791824) | Keymed Biosciences Co.Ltd | 2025-03-01 |
| Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma (NCT06827782) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-03-01 |
| The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial. (NCT02503280) | Joshua M Hare | 2025-03-01 |
| A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients (NCT06788197) | Henan Cancer Hospital | 2025-03-01 |
| taVNS Effects on Fear Ratings in Naturalistic Context (NCT06975124) | University of Electronic Science and Technology of China | 2025-03-01 |
| Efficacy of Tooth Bleaching With 35% and 6% Hydrogen Peroxide in Primary Dentition (NCT05789004) | University of Nove de Julho | 2025-03-01 |
| A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease (NCT06825169) | Nuwacell Biotechnologies Co., Ltd. | 2025-03-01 |
| A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors (NCT06560138) | Atridia Pty Ltd. | 2025-03-01 |
| Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia (NCT06826430) | Juventas Cell Therapy Ltd. | 2025-03-01 |
| The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease (NCT06819514) | Guangzhou Jiayin Biotech Ltd | 2025-03-01 |
| Effects of Esketamine Versus Magnesium Sulfate on Emotional State and Postoperative Pain in Patients Undergoing Nasal Endoscopic Surgery (NCT06920576) | The Second People's Hospital of Huai'an | 2025-03-01 |
| rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage (NCT06814964) | Beijing Tiantan Hospital | 2025-03-01 |
| An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease (NCT06778265) | Shanghai UniXell Biotechnology Co., Ltd | 2025-03-01 |
| Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer (NCT06871527) | Sixth Affiliated Hospital, Sun Yat-sen University | 2025-03-01 |
| Clinical and Radiographic Evaluation of Hyaluronic Acid (Gengigel Teething) Versus Mineral Trioxide Aggregate( Angelus) as Pulpotomy Agent in Vital Primary Molars (NCT06611631) | Cairo University | 2025-03-01 |
| Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge) (NCT06293339) | Leiden University Medical Center | 2025-03-01 |
| Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases (NCT06821659) | Peking University Third Hospital | 2025-03-01 |
| A Phase 1 Study of S-1117 (NCT06828393) | Seismic Therapeutic AU Pty Ltd | 2025-03-01 |
| IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure (NCT06866600) | HELP Therapeutics Co., Ltd. | 2025-03-01 |
| The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC) (NCT06861543) | Peking Union Medical College Hospital | 2025-03-01 |
| Nervus Vagus Stimulation and Cerebral Palsy (NCT06880887) | Istanbul Medipol University Hospital | 2025-03-01 |
| Stem Cell Therapy for Intracerebral Hemorrhage (NCT06862388) | Tang Zhouping | 2025-03-01 |
| Effect of a Vegan Mediterranean Diet on Cardiometabolic Biomarkers, Functional Capacity, and Quality of Life in Patients with Fibromyalgia (NCT06804460) | Universidad Francisco de Vitoria | 2025-03-01 |
| Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo (NCT07044141) | Lahore General Hospital | 2025-03-01 |
| International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma (NCT06839703) | Prof. Dr. Dirk Reinhardt | 2025-03-01 |
| The Study on Effects of CYP3A and P-glycoprotein Inhibitor Itraconazole and CYP Enzyme Inducer Rifampin of HMPL-453 Tartrate Tablets (NCT07697157) | Hutchmed | 2025-03-01 |
| Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients (NCT06968000) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2025-03-01 |
| Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease (NCT06158620) | University of Texas Southwestern Medical Center | 2025-03-01 |
| A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor (NCT05730244) | The University of The West Indies | 2025-03-01 |
| Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma (NCT06741020) | Zhejiang Cancer Hospital | 2025-03-01 |
| Study of SYH2062 Injection in Healthy Chinese Volunteers (NCT06842537) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2025-03-01 |
| Weighted Blankets for IUD Insertion (NCT06969365) | Saint Luke's Health System | 2025-03-01 |
| Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs (NCT06815653) | University College, London | 2025-03-01 |
| NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia (NCT06706414) | Martin Blomberg Jensen | 2025-03-01 |
| Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function (NCT06823245) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-02-28 |
| A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer (NCT06764316) | Bayer | 2025-02-28 |
| BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. (NCT06773312) | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | 2025-02-28 |
| CART123 + Ruxolitinib in Relapsed/Refractory AML (NCT06768476) | University of Pennsylvania | 2025-02-28 |
| Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome (NCT06967038) | Bangdong Gong | 2025-02-28 |
| LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis (NCT06848465) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2025-02-28 |
| A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults (NCT06633562) | Lohocla Research Corporation | 2025-02-28 |
| Precision Antibiotic Dosing for Appendectomy (NCT06860802) | University of Michigan | 2025-02-28 |
| To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers. (NCT06870422) | Teikoku Seiyaku Co., Ltd. | 2025-02-28 |
| A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function (NCT06858696) | X4 Pharmaceuticals | 2025-02-28 |
| Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders (NCT06565637) | Auburn University | 2025-02-28 |
| Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects (NCT06867393) | Shanghai Kechow Pharma, Inc. | 2025-02-28 |
| A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation (NCT06778863) | Clasp Therapeutics, Inc. | 2025-02-28 |
| AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) (NCT06860789) | Akeso | 2025-02-28 |
| Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function (NCT06823258) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-02-28 |
| A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) (NCT06808477) | Bambusa Therapeutics | 2025-02-27 |
| Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy (NCT06653400) | Icahn School of Medicine at Mount Sinai | 2025-02-27 |
| The Potential Effect of the Local Administration of Vitamins C and E on Orthodontic Treatment: A Randomized Clinical Trial (NCT06847880) | University of Baghdad | 2025-02-27 |
| A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005) (NCT06818968) | Merck Sharp & Dohme LLC | 2025-02-27 |
| A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) (NCT06780137) | Merck Sharp & Dohme LLC | 2025-02-27 |
| A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions (NCT06911242) | Arisan Therapeutics, Inc. | 2025-02-27 |
| A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients (NCT06666283) | Alebund Pharmaceuticals | 2025-02-27 |
| ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC (NCT06816992) | ORIC Pharmaceuticals | 2025-02-27 |
| The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity (NCT06830343) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2025-02-27 |